Cost-effectiveness of adjuvant FOLFOX and 5FU/LV chemotherapy for patients with stage II colon cancer
about
Survival analysis and extrapolation modeling of time-to-event clinical trial data for economic evaluation: an alternative approach.Cost-effectiveness analysis of colon cancer treatments from MOSIAC and No. 16968 trialsUS-Based Drug Cost Parameter Estimation for Economic Evaluations.The effect and clinical efficacy of lienal polypeptide injection combined with FOLFOX chemotherapy regimen in colon cancer patients.Building personalized treatment plans for early-stage colorectal cancer patients.Risk Stratification in Patients with Stage II Colon Cancer.
P2860
Cost-effectiveness of adjuvant FOLFOX and 5FU/LV chemotherapy for patients with stage II colon cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost-effectiveness of adjuvant ...... nts with stage II colon cancer
@en
Cost-effectiveness of adjuvant ...... ts with stage II colon cancer.
@nl
type
label
Cost-effectiveness of adjuvant ...... nts with stage II colon cancer
@en
Cost-effectiveness of adjuvant ...... ts with stage II colon cancer.
@nl
prefLabel
Cost-effectiveness of adjuvant ...... nts with stage II colon cancer
@en
Cost-effectiveness of adjuvant ...... ts with stage II colon cancer.
@nl
P2093
P2860
P356
P1476
Cost-effectiveness of adjuvant ...... nts with stage II colon cancer
@en
P2093
Jinghua Shi
Mehmet U S Ayvaci
Oguzhan Alagoz
Sam J Lubner
P2860
P304
P356
10.1177/0272989X12470755
P577
2013-01-11T00:00:00Z